• Je něco špatně v tomto záznamu ?

Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry

L. Pečinka, M. Vlachová, L. Moráň, J. Gregorová, V. Porokh, P. Kovačovicová, M. Almáši, L. Pour, M. Štork, J. Havel, S. Ševčíková, P. Vaňhara

. 2023 ; 34 (12) : 2646-2653. [pub] 20231123

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000291

Monoclonal gammopathies are a group of blood diseases characterized by presence of abnormal immunoglobulins in peripheral blood and/or urine of patients. Multiple myeloma and plasma cell leukemia are monoclonal gammopathies with unclear etiology, caused by malignant transformation of bone marrow plasma cells. Mass spectrometry with matrix-assisted laser desorption/ionization and time-of-flight detection is commonly used for investigation of the peptidome and small proteome of blood plasma with high accuracy, robustness, and cost-effectivity. In addition, mass spectrometry coupled with advanced statistics can be used for molecular profiling, classification, and diagnosis of liquid biopsies and tissue specimens in various malignancies. Despite the fact there have been fully optimized protocols for mass spectrometry of normal blood plasma available for decades, in monoclonal gammopathy patients, the massive alterations of biophysical and biochemical parameters of peripheral blood plasma often limit the mass spectrometry measurements. In this paper, we present a new two-step extraction protocol and demonstrated the enhanced resolution and intensity (>50×) of mass spectra obtained from extracts of peripheral blood plasma from monoclonal gammopathy patients. When coupled with advanced statistics and machine learning, the mass spectra profiles enabled the direct identification, classification, and discrimination of multiple myeloma and plasma cell leukemia patients with high accuracy and precision. A model based on PLS-DA achieved the best performance with 71.5% accuracy (95% confidence interval, CI = 57.1-83.3%) when the 10× repeated 5-fold CV was performed. In summary, the two-step extraction protocol improved the analysis of monoclonal gammopathy peripheral blood plasma samples by mass spectrometry and provided a tool for addressing the complex molecular etiology of monoclonal gammopathies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000291
003      
CZ-PrNML
005      
20240327140724.0
007      
ta
008      
240109s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/jasms.3c00166 $2 doi
035    __
$a (PubMed)37994781
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pečinka, Lukáš, $u Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $d 1994- $7 xx0315645
245    10
$a Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry / $c L. Pečinka, M. Vlachová, L. Moráň, J. Gregorová, V. Porokh, P. Kovačovicová, M. Almáši, L. Pour, M. Štork, J. Havel, S. Ševčíková, P. Vaňhara
520    9_
$a Monoclonal gammopathies are a group of blood diseases characterized by presence of abnormal immunoglobulins in peripheral blood and/or urine of patients. Multiple myeloma and plasma cell leukemia are monoclonal gammopathies with unclear etiology, caused by malignant transformation of bone marrow plasma cells. Mass spectrometry with matrix-assisted laser desorption/ionization and time-of-flight detection is commonly used for investigation of the peptidome and small proteome of blood plasma with high accuracy, robustness, and cost-effectivity. In addition, mass spectrometry coupled with advanced statistics can be used for molecular profiling, classification, and diagnosis of liquid biopsies and tissue specimens in various malignancies. Despite the fact there have been fully optimized protocols for mass spectrometry of normal blood plasma available for decades, in monoclonal gammopathy patients, the massive alterations of biophysical and biochemical parameters of peripheral blood plasma often limit the mass spectrometry measurements. In this paper, we present a new two-step extraction protocol and demonstrated the enhanced resolution and intensity (>50×) of mass spectra obtained from extracts of peripheral blood plasma from monoclonal gammopathy patients. When coupled with advanced statistics and machine learning, the mass spectra profiles enabled the direct identification, classification, and discrimination of multiple myeloma and plasma cell leukemia patients with high accuracy and precision. A model based on PLS-DA achieved the best performance with 71.5% accuracy (95% confidence interval, CI = 57.1-83.3%) when the 10× repeated 5-fold CV was performed. In summary, the two-step extraction protocol improved the analysis of monoclonal gammopathy peripheral blood plasma samples by mass spectrometry and provided a tool for addressing the complex molecular etiology of monoclonal gammopathies.
650    _2
$a lidé $7 D006801
650    _2
$a spektrometrie hmotnostní - ionizace laserem za účasti matrice $x metody $7 D019032
650    12
$a mnohočetný myelom $x diagnóza $7 D009101
650    12
$a plazmocelulární leukemie $7 D007952
650    12
$a paraproteinemie $x diagnóza $7 D010265
650    _2
$a krevní plazma $7 D010949
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vlachová, Monika $u Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic
700    1_
$a Moráň, Lukáš $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Žlutý kopec 7, 602 00 Brno, Czech Republic $7 xx0312627
700    1_
$a Gregorová, Jana $u Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic
700    1_
$a Porokh, Volodymyr $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic
700    1_
$a Kovačovicová, Petra $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic $7 xx0314770
700    1_
$a Almáši, Martina $u Department of Clinical Hematology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000316116289
700    1_
$a Pour, Luděk $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic
700    1_
$a Štork, Martin $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic
700    1_
$a Havel, Josef $u Department of Chemistry, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $1 https://orcid.org/0000000266755671
700    1_
$a Ševčíková, Sabina $u Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic $u Department of Clinical Hematology, University Hospital Brno, Jihlavská 20, 625 00 Brno, Czech Republic
700    1_
$a Vaňhara, Petr $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Kamenice 3, 625 00 Brno, Czech Republic $1 https://orcid.org/000000027470177X $7 xx0106079
773    0_
$w MED00006150 $t Journal of the American Society for Mass Spectrometry $x 1879-1123 $g Roč. 34, č. 12 (2023), s. 2646-2653
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37994781 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240327140720 $b ABA008
999    __
$a ok $b bmc $g 2049136 $s 1209985
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 34 $c 12 $d 2646-2653 $e 20231123 $i 1879-1123 $m Journal of the American Society for Mass Spectrometry $n J Am Soc Mass Spectrom $x MED00006150
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace